In a previous study, we showed that hypermethylation of the p16INK4a gene promoter was present in 36% of mucosa samples obtained 10 cm from the tumor in patients with colorectal cancer.10 The presence of p16INK4a promoter methylation was associated with worse outcomes in the patients. The gene discussed is CDKN2A; the disease is colorectal cancer.